The Technical Analyst
Select Language :
VistaGen Therapeutics Inc [VTGN]

Exchange: NASDAQ Capital Market Sector: Healthcare Industry: Biotechnology

VistaGen Therapeutics Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals

Current Signal: SELL (auto-tracking)

VistaGen Therapeutics Inc is listed at the NASDAQ Exchange

1.97% $0.155

Last updated: 8 aug 2022 - 0:09

TimeZone: America/New_York


FUNDAMENTALS
MarketCap: 32.01 mill
EPS: -0.337
P/E: 0.000
Earnings Date: Aug 10, 2022
SharesOutstanding: 206.64 mill
Avg Daily Volume: 8.25 mill
RATING 2022-08-05
B
Neutral
RATINGDETAILS
Rating CashFlow: Strong Buy
Return On Equity: Sell
Return On Asset: Sell
DE: Neutral
P/E: Strong Sell
Price To Book: Strong Buy
QUARTER GROWTHS
4/201/212/213/214/211/22
Revenue
Gr.Profitn/an/an/a
Ebit
Asset
Debt
Expected Trading Range (DAY)

$ 0.0749 - 0.235

( +/- 51.65%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2022-07-30 Dotson Jerrold Duane Buy 5 000 Common Stock
2022-07-12 Venrock Healthcare Capital Partners Ii, L.p. Sell 60 000 Common Stock
2022-06-30 Smith Mark Alan Buy 5 000 Common Stock
2022-06-30 Singh Shawn Buy 5 000 Common Stock
2022-05-12 Singh Shawn Sell 100 000 Stock Option (Right to Buy)
INSIDER POWER
76.47
Last 100 transactions
Buy: 7 124 024 | Sell: 348 439

Forecast: 16:00 - $0.155

Live Trading Signals (every 1 min)

Forecast 1: 16:00 - $0.155
Forecast 2: 16:00 - $0.155
Forecast 3: 16:00 - $0.155
SCORE
-10.00
Sell
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $0.155 (1.97% )
Volume 19.36 mill
Avg. Vol. 8.25 mill
% of Avg. Vol 234.78 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for VistaGen Therapeutics Inc

Last 12 Months

Last 12 months chart data with high, low, open and close for VistaGen Therapeutics Inc

RSI

Intraday RSI14 chart for VistaGen Therapeutics Inc

Last 10 Buy & Sell Signals For VTGN

141 Signals | Accuracy: 17.02% | Accuracy Buy: 18.31% | Accuracy Sell: 15.71%

Avg return buy: -0.28 % | Avg return sell: 0.32 %

$1 invested is now $0.81 or -18.88% since 25-07-22

Date Signal @ Closed %
Aug 5 - 15:56sell$0.155N/AActive
Aug 5 - 15:55buy$0.155$0.155 @ Aug 5 - 15:56-0.32%
Aug 5 - 15:53sell$0.155$0.155 @ Aug 5 - 15:550.45%
Aug 5 - 15:34buy$0.156$0.155 @ Aug 5 - 15:53-0.51%
Aug 5 - 15:33sell$0.154$0.156 @ Aug 5 - 15:340.97%
Aug 5 - 15:21buy$0.154$0.154 @ Aug 5 - 15:33-0.19%
Aug 5 - 15:14sell$0.153$0.154 @ Aug 5 - 15:210.72%
Aug 5 - 14:58buy$0.155$0.153 @ Aug 5 - 15:14-1.42%
Aug 5 - 14:55sell$0.154$0.155 @ Aug 5 - 14:580.91%
Aug 5 - 14:53buy$0.156$0.154 @ Aug 5 - 14:55-0.96%
The Live Chart for VistaGen Therapeutics Inc
Profile picture for
            VistaGen Therapeutics Inc

VTGN

VistaGen Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of new generation medicines to treat diseases and disorders of the central nervous system. The company is headquartered in South San Francisco, California and currently employs 9 full-time employees. The firm is engaged in developing and commercializing product candidates for patients with diseases and disorders involving the central nervous system (CNS). Its lead product candidate, AV-101, is an orally available prodrug candidate in Phase II development, initially for the adjunctive treatment of major depressive disorder (MDD) in patients with an inadequate response to standard antidepressants approved by the United States Food and Drug Administration (FDA). In addition to AV-101, the Company has developed a human pluripotent stem cell (hPSC) technology platform, which includes its in-vitro bioassay system, CardioSafe 3D, to predict potential heart toxicity of new chemical entities (NCEs) long before testing in animal and human studies. The firm is focused on regenerative medicine (RM) applications using blood, cartilage, heart and/or liver cells derived from hPSCs.

Last 10 Buy Signals
Date Signal @
ADAUSDAug 8 - 00:070.533
SNMUSDAug 8 - 00:060.105
VTCUSDAug 8 - 00:060.151
ZRXUSDAug 8 - 00:050.360
CVCUSDAug 8 - 00:050.163
GASUSDAug 8 - 00:042.98
PIVXUSDAug 8 - 00:030.172
XMRUSDAug 8 - 00:03164.40
BNTUSDAug 8 - 00:030.604
GNOUSDAug 8 - 00:03163.76

Stock Peers

Company Price Change
VTGN0.1551.97%
BLUE5.5922.05%
COGT12.050.50%
KALV13.764.56%
OMIC4.344.58%
PEPG11.27-6.32%
PRLD6.177.68%
STRO5.764.92%
VBIV1.06014.63%
VMD6.540.15%
ZTEK2.25-2.39%

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.